Nutrition for premature infants with bronchopulmonary dysplasia

Neonatal Nutrition and Metabolism, Second Edition

Volumn 9780521824552, Issue , 2006, Pages 522-532

  Atkinson, Stephanie A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846221643     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544712.037     Document Type: Chapter

References (60)

1. Welty, S. E. Antioxidants and oxidations in bronchopulmonary dysplasia: There are no easy answers. J. Pediatr. 2003;43:697-8.
2. Sullivan, J. L. Iron, plasma antioxidants, and the ‘oxygen radical disease of prematurity’. Am. J. Dis. Child. 1988;142:1341-44.
3. Saugstad, O. D. Bronchopulmonary dysplasia-oxidative stress and antioxidants. Semin. Neonatol. 2003;8:39-49.
4. Pitkanen, O. M., Hallman, M. Evidence for increased oxidative stress in preterm infants eventually developing chronic lung disease. Semin. Neonatol. 1998;3:199-205.
5. Jankov, R.P., Negus, A., Tanswell, A. K. Antioxidants as therapy in the newborn: Somewords of caution. Pediatr. Res. 2001;50:681-7.
6. Welty, S. E. Is there a role for antioxidant therapy in bronchopulmonary dysplasia? J. Nutr. 2001:131;947S-50S.
7. Welty, S. E., Smith, C.V. Rationale for antioxidant therapy in premature infants to prevent bronchopulmonary dysplasia. Nutr. Rev. 2001;59:10-17.
8. Watts, J. L., Milner, R., Zipursky, A. et al. Failure of supplementation with vitamin E to prevent bronchopulmonary dysplasia in infants less than 1, 500 g birth weight. Eur. Respir. J.1991;4:188-90.
9. Berger, T. M., Frei, B., Rifai, N. et al.Early high dose antioxidant vitamins do not prevent bonchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: A pilot study. Pediatr. Res. 1998;43:719-26.
10. Specker, B. L., deMarini, S., Tsang, R. C. Vitamin and mineral supplementation. In Sinclair, J. C., Bracken, M. B., eds. Effective Care of the Newborn. New York: Oxford University Press; 1992:161-77.
11. Merz, U., Peschgens, T., Dott, W., Hornchen, H. Selenium status and bronchopulmonary dysplasia in premature infants <1, 500 g. Z. Geburtshilfe Neonatol. 1998;202:203-6.
12. Darlow, B. A., Inder, T. E., Graham, P. J. et al.The relationship of selenium status to respiratory outcome in the very low birth weight infant. Pediatrics1995;96:314-19.
13. Falciglia, H. S., Johnson, R. J., Sullivan, J. et al. Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Am. J. Perinatol. 2003;20:97-108.
14. Ahola, T., Lapatto, R., Raivo, K. O. et al.N-acetylcysteine does not prevent bronchopumonary dysplasia in immature infants: A randomized controlled trial. J. Pediatr. 2003;143:713-19.
15. Rosenfeld, W., Evans, H., Concepcion, L. et al.Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J. Pediatr. 1984;105:781-5.
16. Davis, J. M., Richter, S. E., Biswas, S. et al.Long-term followup of premature infants treated with prophylactic intratracheal recombinant human CuZn superoxide dismutase. J. Perinatol. 2000;20:213-16.
17. Bromberger, P., Hallman, M. Myoinositol in small preterm infants:Relationship between intake and serumconcentration. J. Pediatr. Gastroenterol. Nutr. 1986:5:455-8.
18. Pereira, G. R., Baker, L., Egler, J., Corcoran, L., Chiavacci, R. Serum myoinositol concentrations in premature infants fed human milk, formula for infants, and parenteral nutrition. Am. J. Clin. Nutr. 1990;51:589-93.
19. Hallman, M., Arjomaa, P., Hoppu, K. Inositol supplementation in respiratory distress syndrome: Relationship between serum concentration, renal excretion, and lung effluent phospholipids. J. Pediatr. 1987;110:604-10.
20. Hallman, M., Bry, K., Hoppu Lappi, M., Pohjavuori, M. Inositol supplementation in premature infants with respiratory distress syndrome. N. Engl. J.Med. 1992;326:1233-9.
21. Howlett, A., Ohlsson, A. Inositol for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2003;4:CD000366.
22. Koo, W. W. K., Krug-Wispe, S., Succop, P., Tsang, R. C., Neylan, M. Effects of different vitamin A intakes in very lowbirthweight infants. Am. J. Clin. Nutr. 1995;62;1216-20.
23. Green, H., Phillips, B. L., Franck, L. et al.Persistently low blood retinal levels during and after parenteral feeding of very low birth weight infants: Examination of losses into intravenous administration sets and a method of prevention by addition to a lipid emulsion. Pediatrics1987:79:894-900.
24. Darlow, B. A., Graham, P. J. Vitamin A supplementation for preventingmorbidityandmortality in verylowbirthweight infants. Cochrane Database Syst Rev. 2000;2:CD000501.
25. Tyson, J. E., Wright, L. L., Oh, W. et al.Vitamin A supplementation for extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N. Eng. J.Med. 1999;340:1962-8.
26. Ambalavanan, N., Wu, T.-J., Tyson, J. E. A comparison of three vitaminAdosing regimens in extremely-low-birth-weight infants. J. Pediatr. 2003;142:656-61.
27. Kramer, M. S., Platt, R.W., Shi, W.W. et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics2001;108:1-7.
28. Ziegler, E. E., Biga, R. L., Fomon, S. J. Nutritional requirements of the premature infant. InSuskind, R. M., ed. Textbook ofPediatric Nutrition. New York: Raven Press;1981:29.
29. Brunton, J. A., Saigal, S., Atkinson, S. A. Growth and body composition in infants with bronchopulmonary dysplasia up to 3 months corrected age: A randomized trial of a high-energy nutrient-enriched formula fed after hospital discharge. J. Pediatr. 1998;133:340-5.
30. Denne, S. C. Energy expenditure in infants with pulmonary insufficiency: Is there evidence for increased energy needs. J. Nutr. 2001;131:935S-7S.
31. Brunton, J. A., Atkinson, S. A., Winthrop, A., Saigal, S. Measures of energy intake and expenditure by doubly labeled water in infants recovering from bronchopulmonary dysplasia up to 3 months corrected age. Pediatr. Res. 1996;39:305A.
32. Davies, P. S.W., Irving, G., Lucas, A. Energy expenditure in early infancy. Br. J. Nutr. 1989;62:621-9.
33. Leitch, C. A., Denne, S. C. Increased energy expenditure in premature infants with chronic lung disease. Pediatr. Res. 2000;47:291
34. St John, E. B., Carlo, W. A. Respiratory distress syndrome in VLBWinfants:changesinmanagementandoutcomesobserved by the NICHD Neonatal Research Network. Semin. Perinatol. 2003;27:288-92.
35. Weiler, H. A., Paes, B., Shah, J. K., Atkinson, S. A. Longitudinal assessment of growth and bone mineral accretion in prematurely born infants treated for chronic lung disease with dexamethasone. Early Hum. Dev.1997;47:271-86.
36. Ward, W. E., Atkinson, S. A., Donovan, S., Paes, B. Bone metabolism and circulating IGF-I and IGFBPs in dexamethasone-treated preterm infants. Early Hum. Dev.1999;56:127-41.
37. Weiler, H. A., Wang, Z., Atkinson, S. A. Whole body lean mass is altered by dexamethasone treatment through reductions in protein and energy utilization in piglets. Biol. Neonate1997b;71:53-9.
38. Leitch, C. A., Ahlrichs, J., Karn, C., Denne, S. C. Energy expenditure and energy intake during dexamethasone therapy for chronic lung disease. Pediatr. Res. 1999;46:109-13.
39. Weiler, H., Wang, Z., Atkinson, S. A. Dexamethasone alters calcium metabolism and bone mineralization during early development in the piglet model. Am. J. Clin. Nutr. 1995;61:805-11.
40. Ward, W. E., Donovan, S. M., Atkinson, S. A. Dexamethasoneinduced abnormalities in bone metabolism in piglets are partially attenuated by growth hormone with no synergistic effect of insulin-like growth factor-1. Pediatr. Res. 1998;44:215-21.
41. Weiler, H. A., Atkinson, S. A. Dietary intervention following dexamethasone (DEX) treatment is effective in ameliorating dexamethasone-induced growth delay and osteoporosis in infant pigs. Am. J. Clin. Nutr. 1995;61:910.
42. Shinwell, E. S., Karplus, M., Bader, D. et al. Neonatologists are usingmuchlessdexamethasone. Arch.Dis.ChildFetalNeonatal Edn. 2003;88:F432-3.
43. Fewtrell, M. S., Adams, C., Wilson, D. C. et al. Randomized trial of high nutrient density formulas versus standard formula in chronic lung disease. Acta Pediatr. 1197;86:577-82.
44. Kay, H. H., Bird, I. M., Coe, C. L., Dudley, D. J. Antenatal steroid treatment and adverse fetal effects: What is the evidence? J. Soc. Gynecol. Investig. 2000;7:269-78.
45. Brunton, J. A., Saigal, S., Atkinson, S. A. Nutrient intake similar to recommended values does not result in catch-up growth by 12moof age in very lowbirthweight infants (VLBW) with bronchopulmonary dysplasia (BPD). Am. Soc. Clin. Nutr. 1997;102.
46. Atkinson, S. A. Special nutritional needs of infants for prevention of and recovery frombronchopulmonary dysplasia. J.Nutr. 2001;131:942S-6S.
47. Puangco, M. A., Schanler, R. J. Clinical experience in enteral nutrition support for premature infants with bronchopulmonary dysplasia. J. Perinatol. 2000;20:87-91.
48. Huysman, W. A., de Ridder, M., de Bruin, N. C. et al.Growth and body composition in preterm infants with bronchopulmonary dysplasia. Arch.Dis. Child FetalNeonatal Edn. 2003;88: F46-F51.
49. Butte, N., Heinz, C., Hopkinson, J. et al.Fat mass in infants and toddlers: Comparability of total body water, total body potassium, total body electrical conductivity and dual energy X-ray absorptiometry. J. Pediatr. Gastroenterol. Nutr. 1999;29: 184-9.
50. Randall Simpson, J., Paes, B., Thompson, P., Atkinson, S. A. Body composition analysis by dual energy x-ray absorptiometery (DXA) of term infants from birth to 12 months. Am. J. Clin. Nutr. 1995;61:500.
51. Atkinson, S. A., Randall-Simpson, J. Factors influencing body composition of premature infants at term-adjusted age. In Yasumura, S., ed. Annals New York Academy of Sciences. 5th International Symposium on In Vivo Body Composition Studies, New York. 2000;904:393-400.
52. Mimouni, F., Campaigne, B., Neylan, M., Tsang, R. C. Bone mineralization in the first year of life in infants fedhumanmilk, cowmilk formula or soy-based formula. J. Pediatr. 1993;122:348-54.
53. Nutrition Committee, Canadian Pediatric Society. Nutrient needs and feeding of premature infants. Can. Med. Assoc. J.1995;152:1765-85.
54. Institute of Medicine. Dietary Reference Intake for Calcium, Phosphorus, Magnesium, Vitamin D and Fluoride. Food and Nutrition Board. Washington, DC: National Academy Press; 1997.
55. Vrlenich, L. A., Bozynski, M. E. A., Shyr, Y. et al.The effect of bronchopulmonary dysplasia on growth at school age. Pediatrics1995;95:855-9.
56. Robertson, C. M. T., Etches, P. C., Goldson, E., Kyle, J. M. Eight yearschoolperformance, neurodevelopmentalandgrowthoutcome of neonates with bronchopulmonary dysplasia: A comparative study. Pediatrics1992;89:365-72.
57. Giacoia, P. G., Venkataraman, S.P., Kerstin, I., West, W., Faulkner, M. J. Follow-up of school age children with bronchopulmonary dysplasia. J. Pediatr. 1997;130:400-8.
58. Korhonen, P., Hyodynmaa, E., Lenko, H.-L., Tammela, O. Growth and adrenal androgen status at 7 years in very low birth weight survivors with and without bronchopulmonary dysplasia. Arch. Dis. Child. 2004;89:320-4.
59. Northway, W. H., Moss, R. B., Carlisle, K. B. et al.Late pulmonary sequelae of bronchopulmonary dysplasia. N. Engl. J. Med. 1990;323:1793-9.
60. Koivisto, M., Marttila, R., Kurkinen-Raty, M. et al.Changing incidence and outcome of infants with respiratory distress syndrome in the 1990s: A population-based survey. Acta Pediatr. 2004;93:177-84.